首页> 美国卫生研究院文献>Pharmaceutical Biology >Effects of rosmarinic acid on acetaminophen-induced hepatotoxicity in male Wistar rats
【2h】

Effects of rosmarinic acid on acetaminophen-induced hepatotoxicity in male Wistar rats

机译:迷迭香酸对对乙酰氨基酚诱导的雄性Wistar大鼠肝毒性的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Context: Drug-induced liver injury is a significant worldwide clinical problem. Rosmarinic acid (RA), a natural phenol, has antioxidant effects. >Objective: The effects of RA against acetaminophen (N-acetyl-p-amino-phenol (APAP))-induced oxidative damage and hepatotoxicity in rats were investigated. >Materials and methods: Male Wistar rats were pretreated with RA (10, 50 and 100 mg/kg, i.g.) for one week. On day 7, rats received APAP (500 mg/kg, i.p.). Then aspartate aminotransferase (AST), alanine aminotransferase (ALT), albumin, total protein, malondialdehyde (MDA), glutathione (GSH), total antioxidant capacity (TAC), glutathione S-transferase (GST), cytochrome CYP450 and histopathological changes were determined. >Results: APAP-induced oxidative stress in liver by a significant increase in the level of MDA (7.6 ± 0.21 nmol/mg) as well as a decrease in the contents of TAC (1.75 ± 0.14 μmol/g), GSH (1.9 ± 0.22 μmol/g) and GST) 3.2 ± 0.28 U/mg). RA treatment decreased MDA (4.32 ± 0.35 nmol/mg) but increased the contents of TAC (3.51 ± 0.34 μmol/g), GSH (3.42 ± 0.16 μmol/g) and GST (5.71 ± 0.71 μmol/g) in APAP group. RA 100 mg/kg decreased ALT (91.5 ± 1.5 U/L), AST (169 ± 8.8 U/L) and CYP450 (3 ± 0.2 nmol/min/mg) in APAP group. Histologically RA attenuated hepatic damage by decreasing necrosis, inflammation, and haemorrhage in liver sections of APAP group. >Discussion and conclusions: This is the first report that oral administration of RA dose-dependently elicited significant hepatoprotective effects in rats through inhibition of hepatic CYP2E1 activity and lipid peroxidation. RA-protected hepatic GSH and GST reserves and total tissue antioxidant capacity.
机译:>背景:药物性肝损伤是一个重要的全球性临床问题。天然酚迷迭香酸(RA)具有抗氧化作用。 >目的:研究了RA对对乙酰氨基酚(N-乙酰-对氨基苯酚(APAP))诱导的大鼠氧化损伤和肝毒性的影响。 >材料和方法:雄性Wistar大鼠用RA(10、50和100μmg/ kg,例如,i.g。)预处理一周。在第7天,大鼠接受APAP(500μg/ kg,腹腔注射)。然后测定了天冬氨酸转氨酶(AST),丙氨酸转氨酶(ALT),白蛋白,总蛋白,丙二醛(MDA),谷胱甘肽(GSH),总抗氧化能力(TAC),谷胱甘肽S-转移酶(GST),细胞色素CYP450和组织病理学变化。 >结果: APAP引起的肝脏氧化应激,MDA含量显着增加(7.6±0.21 nmol / mg),而TAC含量降低(1.75±0.14μmol/ g) ),GSH(1.9±0.22μmol/ g和GST)3.2±0.28 U / mg)。 RA治疗使APAP组的MDA降低(4.32±0.35nmol / mg),但增加了TAC(3.51±0.34μmol/ g),GSH(3.42±0.16μmol/ g)和GST(5.71±0.71μmol/ g)的含量。 APAP组RA 100 mg / kg降低ALT(91.5±1.5 U / L),AST(169±8.8 U / L)和CYP450(3±0.2 nmol / min / mg)。组织学上,RA通过减少APAP组肝脏切片中的坏死,炎症和出血减轻了肝损伤。 >讨论和结论:这是第一篇关于口服RA剂量依赖性抑制大鼠肝CYP2E1活性和脂质过氧化作用的报告,认为其剂量依赖性地引起大鼠明显的肝保护作用。 RA保护的肝脏GSH和GST储备和总组织抗氧化能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号